These findings are consistent with those of previous in vitro studies across several cancer types, including glioblastoma, melanoma, colorectal cancer, and neuroblastoma, where wild-type PTPRD has been observed to suppress colony formation and cell growth as well as enhance apoptosis, while cancer-derived PTPRD mutants do not. Here, PTPRD is linked to neuroblastoma.